T-NeuroPharma
Using T-Cells to Track and Treat Neurodegenerative Diseases
Using T-Cells to Track and Treat Neurodegenerative Diseases
TNeuroPharma is a biotechnology startup founded in 2018 and headquartered in Albuquerque, New Mexico. The company's slogan, "Pioneering early detection and treatment of Alzheimer's through innovative T-cell technology for a healthier future," encapsulates its focus on using therapeutic technology to address the role of T-cells in the detection and treatment of neurodegenerative diseases. Specifically, their innovative approach involves identifying dysfunctional T-cells through blood samples to detect Alzheimer's disease at an early stage, allowing for timely treatment and prevention of future complications.
The company recently received a $25.00K grant investment on 31 March 2022, with the funding coming from the New Mexico Economic Development Department. TNeuroPharma operates within the Biotechnology and Health Care industries, positioning itself at the forefront of pioneering advancements in the early detection and treatment of Alzheimer's disease.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $25.00K | 1 | New Mexico Economic Development Department | 31 Mar 2022 |
| Seed Round | Unknown | 1 |
|
18 May 2021 |
No recent news or press coverage available for T-NeuroPharma.
We care about your data, and we'd love to use cookies make your experience better.